“If you’re a huge company trying to develop a new drug or treatment, the temptation to hide ‘bad’ results might be a strong one. Until now, you would be able to hide those results with few consequences.”

In this Wired article, Abigail Beall, discusses the Alltrials campaign and the FDAAA TrialsTracker